Cargando…

Regional Chemotherapy in Locally Advanced Pancreatic Cancer: RECLAP Trial

BACKGROUND: Pancreatic cancer is the fourth leading cause of cancer death in the United States. Surgery offers the only chance for cure. However, less than twenty percent of patients are considered operative candidates at the time of diagnosis. A common reason for being classified as unresectable is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Davis, Jeremy L, Pandalai, Prakash, Ripley, R Taylor, Langan, Russell C, Steinberg, Seth M, Walker, Melissa, Toomey, Mary Ann, Levy, Elliot, Avital, Itzhak
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3118359/ https://www.ncbi.nlm.nih.gov/pubmed/21595953 http://dx.doi.org/10.1186/1745-6215-12-129

Ejemplares similares

Prospective randomized trial evaluating mandatory second look surgery with HIPEC and CRS vs. standard of care in patients at high risk of developing colorectal peritoneal metastases
por: Ripley, Robert T, et al.
Publicado: (2010)

Liver Directed Therapy for Renal Cell Carcinoma
por: Langan, Russell C., et al.
Publicado: (2012)

The GYMSSA trial: a prospective randomized trial comparing gastrectomy, metastasectomy plus systemic therapy versus systemic therapy alone
por: Kerkar, Sid P, et al.
Publicado: (2009)

Metabolomic and BH3 profiling of esophageal cancers: novel assessment methods for precision therapy
por: Taylor Ripley, R., et al.
Publicado: (2018)

Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
por: Riggs, McKayla J., et al.
Publicado: (2020)

Colorectal Cancer Biomarkers and the Potential Role of Cancer Stem Cells
por: Langan, Russell C., et al.
Publicado: (2013)

Current Trends in Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Disease from Appendiceal and Colorectal Malignancies
por: Harper, Megan M., et al.
Publicado: (2022)

An Organotypic Microcosm for the Pancreatic Tumor Microenvironment
por: Lin, Miranda, et al.
Publicado: (2020)

Namodenoson Inhibits the Growth of Pancreatic Carcinoma via Deregulation of the Wnt/β-catenin, NF-κB, and RAS Signaling Pathways
por: Itzhak, Inbal, et al.
Publicado: (2023)

Concurrent hysterectomy and bilateral salpingo-oophorectomy during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for non-gynecologic cancers
por: Riggs, McKayla J., et al.
Publicado: (2020)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in treatment of gastric cancer with peritoneal carcinomatosis
por: Ellison, Lynne M., et al.
Publicado: (2017)

A Pilot Study Assessing the Potential Role of non-CD133 Colorectal Cancer Stem Cells as Biomarkers
por: Langan, Russell C., et al.
Publicado: (2012)

Protocol for Studying Reprogramming of Mouse Pancreatic Acinar Cells to β-like Cells
por: Elhanani, Ofer, et al.
Publicado: (2020)

Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): study protocol for a randomized controlled trial
por: Walma, M. S., et al.
Publicado: (2021)

Loss of PDPK1 abrogates resistance to gemcitabine in label-retaining pancreatic cancer cells
por: Li, Dandan, et al.
Publicado: (2018)

Barriers and facilitators to the implementation of social robots for older adults and people with dementia: a scoping review protocol
por: Koh, Wei Qi, et al.
Publicado: (2021)

Serum-Based DNA Methylation Biomarkers in Colorectal Cancer: Potential for Screening and Early Detection
por: Summers, Thomas, et al.
Publicado: (2013)

Comparing Conventional Chemotherapy to Chronomodulated Chemotherapy for Cancer Treatment: Protocol for a Systematic Review
por: Kilgallen, Aoife B, et al.
Publicado: (2020)

Neoadjuvant Chemotherapy with Gemcitabine Plus Nab-Paclitaxel Regimen for Borderline Resectable Pancreatic Cancer with Arterial Involvement: A Prospective Multicenter Single-Arm Phase II Study Protocol
por: Miyasaka, Yoshihiro, et al.
Publicado: (2021)

Rationale and design of PROSPECT-CONKO 004: a prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy)
por: Riess, Hanno, et al.
Publicado: (2008)

Neoadjuvant chemotherapy versus surgery first for resectable pancreatic cancer (Norwegian Pancreatic Cancer Trial - 1 (NorPACT-1)) – study protocol for a national multicentre randomized controlled trial
por: Labori, Knut Jørgen, et al.
Publicado: (2017)

Establishment of Human Ultra-Low Passage Colorectal Cancer Cell Lines Using Spheroids from Fresh Surgical Specimens Suitable for In Vitro and In Vivo Studies
por: Ray, Satyajit, et al.
Publicado: (2012)

Innervated mouse pancreas organoids as an ex vivo model to study pancreatic neuropathy in pancreatic cancer
por: Besikcioglu, H. Erdinc, et al.
Publicado: (2021)

Interaction of immune checkpoint PD-1 and chemokine receptor 4 (CXCR4) promotes a malignant phenotype in pancreatic cancer cells
por: Harper, Megan M., et al.
Publicado: (2022)

Development, Testing, and Implementation of the Belgian Patient Reported Experience Measure for Pancreatic Cancer Care (PREPARE) Project: Protocol for a Multi-Method Research Project
por: Moens, Katrien, et al.
Publicado: (2022)

Generation of Pancreatic Organoid-Derived Isografts
por: D’Agosto, Sabrina, et al.
Publicado: (2020)

Strategies for implementing pet robots in care homes and nursing homes for residents with dementia: protocol for a modified Delphi study
por: Koh, Wei Qi, et al.
Publicado: (2022)

Special Issue on Precision Risk Stratification-Based Screening in Colorectal Cancer
por: Stojadinovic, Alexander, et al.
Publicado: (2013)

Role of multi-modality therapy in peritoneal carcinomatosis and visceral metastasis: a case report and review of the literature
por: Vicente, Diego, et al.
Publicado: (2015)

Endogenous Pancreatic Cancer Cell PD-1 Activates MET and Induces Epithelial-Mesenchymal Transition to Promote Cancer Progression
por: Harper, Megan M., et al.
Publicado: (2022)

Preoperative chemotherapy and carbon ions therapy for treatment of resectable and borderline resectable pancreatic adenocarcinoma: a prospective, phase II, multicentre, single-arm study
por: Vitolo, Viviana, et al.
Publicado: (2019)

Designing Ruby: Protocol for a 2-Arm, Brief, Digital Randomized Controlled Trial for Internalized Weight Bias
por: Hopkins, Christina M, et al.
Publicado: (2021)

Comparison of FOLFIRINOX vs Gemcitabine Plus Nab-Paclitaxel as First-Line Chemotherapy for Metastatic Pancreatic Ductal Adenocarcinoma
por: Klein-Brill, Avital, et al.
Publicado: (2022)

Establishment of Pancreatic Organoids from Normal Tissue and Tumors
por: Driehuis, Else, et al.
Publicado: (2020)

Barriers and enablers to screening and diagnosing depression and diabetes distress in people with type 2 diabetes mellitus; protocol of a qualitative evidence synthesis
por: McGrath, Niamh, et al.
Publicado: (2020)

Proposed pathway for patients undergoing enhanced recovery after spinal surgery: protocol for a systematic review
por: Licina, Ana, et al.
Publicado: (2020)

A Simple, Rapid, and Effective Heparinase Protocol to Enable Nucleic Acid Study from Frozen Heparinized Plasma
por: Afruza, Rownock, et al.
Publicado: (2023)

Updated protocol: Effects of second responder programs on repeat incidents of family abuse: An updated systematic review and meta‐analysis
por: Davis, Robert C., et al.
Publicado: (2021)

Chemotherapy in Pancreatic Cancer: A Systematic Review
por: Hajatdoost, Leva, et al.
Publicado: (2018)

An intrasplenic injection model of pancreatic cancer metastasis to the liver in mice
por: O’Brien, Megan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_co7ehiajv24703ufum3g6i2mjg